{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:37:19Z","timestamp":1766428639694,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.waojou.2020.100454","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:54:57Z","timestamp":1597053297000},"page":"100454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Does hereditary angioedema make COVID-19 worse?"],"prefix":"10.1016","volume":"13","author":[{"given":"Yingyang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-6650","authenticated-orcid":false,"given":"Yuxiang","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2020.100454_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.waojou.2020.100454_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.waojou.2020.100454_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57555","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome","volume":"9","author":"van de Veerdonk","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.waojou.2020.100454_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.14343","article-title":"Off-target ACE2 ligands: possible therapeutic option for CoVid-19?","author":"Brogi","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.waojou.2020.100454_bib5","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202000967","article-title":"A\u00a0hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications","author":"Roche","year":"2020","journal-title":"Faseb J"},{"key":"10.1016\/j.waojou.2020.100454_bib6","article-title":"Complement as a target in COVID-19?","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib7","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100454_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","article-title":"Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies","volume":"13","author":"Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.waojou.2020.100454_bib9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100454_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10238-018-0499-0","article-title":"The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema","volume":"18","author":"Arcoleo","year":"2018","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.waojou.2020.100454_bib11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH10-01-0073","article-title":"C1 inhibitor, a multi-functional serine protease inhibitor","volume":"104","author":"Davis","year":"2010","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.waojou.2020.100454_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1084\/jem.133.4.696","article-title":"A\u00a0prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin","volume":"133","author":"Kaplan","year":"1971","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.waojou.2020.100454_bib13","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1016\/S0021-9258(20)79699-7","article-title":"Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate","volume":"255","author":"Silverberg","year":"1980","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.waojou.2020.100454_bib14","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1073\/pnas.73.11.4179","article-title":"Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma","volume":"73","author":"Mandle","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.waojou.2020.100454_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12016-016-8555-6","article-title":"Complement, kinins, and hereditary angioedema: mechanisms of plasma instability when C1 inhibitor is absent","volume":"51","author":"Kaplan","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","article-title":"Local bradykinin generation in hereditary angioedema","volume":"104","author":"Nussberger","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/0006-2952(86)90726-4","article-title":"Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme","volume":"35","author":"Sheikh","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.waojou.2020.100454_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaci.2016.02.041","article-title":"Angioedema attacks in patients with hereditary angioedema: local manifestations of a systemic activation process","volume":"138","author":"Hofman","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences","volume":"57","author":"Leeb-Lundberg","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.waojou.2020.100454_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/mol.56.2.325","article-title":"Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1 beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts","volume":"56","author":"Phagoo","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.waojou.2020.100454_bib21","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.169.4.2054","article-title":"Up-regulation of functional kinin B1 receptors in allergic airway inflammation","volume":"169","author":"Christiansen","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.waojou.2020.100454_bib23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.12648","article-title":"Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations","volume":"70","author":"Bork","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100454_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/all.13076","article-title":"Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII)","volume":"72","author":"Bork","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100454_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib26","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/all.13869","article-title":"Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin","volume":"74","author":"Bork","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100454_bib27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.waojou.2020.100454_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.waojou.2020.100454_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.waojou.2020.100454_bib30","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.waojou.2020.100454_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.coph.2008.11.011","article-title":"The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease","volume":"9","author":"Duchene","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.waojou.2020.100454_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-201X.1997.549324000.x","article-title":"Effects of bradykinin, histamine and serotonin on pulmonary vascular resistance and permeability","volume":"159","author":"Breil","year":"1997","journal-title":"Acta Physiol Scand"},{"year":"2020","series-title":"Blood Pressure Management Recommendation for Patients with Novel Coronavirus Pneumonia","author":"Liu","key":"10.1016\/j.waojou.2020.100454_bib33"},{"key":"10.1016\/j.waojou.2020.100454_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100454_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A\u00a0randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Ba\u015f","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100454_bib36","series-title":"Research and Practice in Thrombosis and Haemostasis","article-title":"The contact activation system as a potential therapeutic target in patients\u00a0with COVID-19","author":"Shatzel","year":"2020"},{"key":"10.1016\/j.waojou.2020.100454_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-3083.1996.d01-298.x","article-title":"Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema","volume":"44","author":"Nielsen","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib38","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.waojou.2020.100454_bib39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/all.12587","article-title":"Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk","volume":"70","author":"Reshef","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100454_bib40","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.waojou.2020.100454_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100454_bib42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.waojou.2020.100454_bib43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100454_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2019.04.030","article-title":"The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases","volume":"179","author":"Iba","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.waojou.2020.100454_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00005-008-0004-7","article-title":"Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults","volume":"56","author":"Cedzy\u0144ski","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.waojou.2020.100454_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2008.03671.x","article-title":"Depressed activation of the lectin pathway of complement in hereditary angioedema","volume":"153","author":"Varga","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.05.030","article-title":"Activation of the ficolin-lectin pathway during attacks of hereditary angioedema","volume":"134","author":"Csuka","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib48","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.194.11.1609","article-title":"Complement 1 inhibitor is a regulator of the alternative complement pathway","volume":"194","author":"Jiang","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.waojou.2020.100454_bib49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-3083.1995.tb03711.x","article-title":"C3 is activated in hereditary angioedema, and C1\/C1-inhibitor complexes rise during physical stress in untreated patients","volume":"42","author":"Nielsen","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib50","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over- activation","author":"Gao","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.waojou.2020.100454_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"issue":"5","key":"10.1016\/j.waojou.2020.100454_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.waojou.2020.100454_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.waojou.2020.100454_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","article-title":"Th17 cell development: from the cradle to the grave","volume":"252","author":"Z\u00fa\u00f1iga","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.waojou.2020.100454_bib56","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/ni.1783","article-title":"Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation","volume":"10","author":"Marks","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.waojou.2020.100454_bib58","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.waojou.2020.100454_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaci.2016.09.032","article-title":"Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: implications for hereditary angioedema","volume":"140","author":"Joseph","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100454_bib61","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.waojou.2020.100454_bib62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.waojou.2020.100454_bib63","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.waojou.2020.100454_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-006-0019-9","article-title":"Interleukin-6 and its receptor: from bench to bedside","volume":"195","author":"Scheller","year":"2006","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib65","doi-asserted-by":"crossref","DOI":"10.1254\/jphs.SRJ05001X","article-title":"The kallikrein-kinin system: current and future pharmacological targets","volume":"99","author":"Moreau","year":"2005","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.waojou.2020.100454_bib66","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2019.02046","article-title":"Plasminflammation-an emerging pathway to bradykinin production","volume":"10","author":"Maas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib67","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4049\/jimmunol.170.3.1374","article-title":"Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments","volume":"170","author":"Ambrus","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2020.100454_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16938","article-title":"C1-INH and the contact system in COVID-19-associated coagulopathy","author":"Thomson","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.waojou.2020.100454_bib69","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region","volume":"323","author":"Grasselli","year":"2020","journal-title":"Italy. JAMA."},{"key":"10.1016\/j.waojou.2020.100454_bib70","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1530\/ERC-20-0133","article-title":"Androgen hazards with COVID-19","volume":"27","author":"Sharifi","year":"2020","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.waojou.2020.100454_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2009.12.022","article-title":"Androgen receptor and androgen-dependent gene expression in lung","volume":"317","author":"Mikkonen","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"20","key":"10.1016\/j.waojou.2020.100454_bib72","article-title":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)","volume":"S0923\u20137534","author":"Montopoli","year":"2020","journal-title":"Ann Oncol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:15Z","timestamp":1761849735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120303574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1939455120303574"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100454","relation":{},"ISSN":["1939-4551"],"issn-type":[{"type":"print","value":"1939-4551"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does hereditary angioedema make COVID-19 worse?","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100454"}}